share_log

OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.

Benzinga ·  Nov 13 16:35
OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment